These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8536379)

  • 1. Decreased release of IL-10 by monocytes from patients with lipoid nephrosis.
    Matsumoto K
    Clin Exp Immunol; 1995 Dec; 102(3):603-7. PubMed ID: 8536379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased production of interleukin-1 by monocytes from patients with lipoid nephrosis.
    Matsumoto K
    Clin Nephrol; 1989 Jun; 31(6):292-6. PubMed ID: 2787718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 10 and interleukin 13 synergize to inhibit vascular permeability factor release by peripheral blood mononuclear cells from patients with lipoid nephrosis.
    Matsumoto K; Ohi H; Kanmatsuse K
    Nephron; 1997; 77(2):212-8. PubMed ID: 9346389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased IL-12 release by monocytes in nephrotic patients.
    Matsumoto K; Kanmatsuse K
    Clin Exp Immunol; 1999 Aug; 117(2):361-7. PubMed ID: 10444271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 12 upregulates the release of vascular permeability factor by peripheral blood mononuclear cells from patients with lipoid nephrosis.
    Matsumoto K; Ohi H; Kanmatsuse K
    Nephron; 1998; 78(4):403-9. PubMed ID: 9578066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 10 inhibits vascular permeability factor release by peripheral blood mononuclear cells in patients with lipoid nephrosis.
    Matsumoto K
    Nephron; 1997; 75(2):154-9. PubMed ID: 9041534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-15 and interleukin-12 have an additive effect on the release of vascular permeability factor by peripheral blood mononuclear cells in normals and in patients with nephrotic syndrome.
    Matsumoto K; Kanmatsuse K
    Clin Nephrol; 1999 Jul; 52(1):10-8. PubMed ID: 10442490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmented interleukin-18 production by peripheral blood monocytes in patients with minimal-change nephrotic syndrome.
    Matsumoto K; Kanmatsuse K
    Am J Nephrol; 2001; 21(1):20-7. PubMed ID: 11275628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-4 cooperates with interleukin-10 to inhibit vascular permeability factor release by peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome.
    Matsumoto K; Ohi H; Kanmatsuse K
    Am J Nephrol; 1999; 19(1):21-7. PubMed ID: 10085445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant granulocyte-macrophage colony-stimulating factor modulates in vitro function of the peripheral blood mononuclear cells in lipoid nephrosis.
    Matsumoto K; Yasugi T
    Am J Nephrol; 1993; 13(2):100-6. PubMed ID: 8342574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta1 inhibits vascular permeability factor release by T cells in normal subjects and in patients with minimal-change nephrotic syndrome.
    Matsumoto K; Kanmatsuse K
    Nephron; 2001 Feb; 87(2):111-7. PubMed ID: 11244304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-8 release from cultured peripheral blood monocytes of patients with glomerulonephritis.
    Matsumoto K
    Clin Exp Immunol; 1995 Jan; 99(1):106-11. PubMed ID: 7813101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous and lipopolysaccharide-stimulated secretion of cytokines by peripheral blood monocytes in IgA nephropathy is inhibited by interleukin-10.
    Matsumoto K
    Nephron; 1996; 73(2):305-9. PubMed ID: 8773361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased release of tumor necrosis factor-alpha by monocytes from patients with glomerulonephritis.
    Matsumoto K
    Clin Nephrol; 1993 Sep; 40(3):148-54. PubMed ID: 8403569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of interleukin-15 on vascular permeability factor release by peripheral blood mononuclear cells in normal subjects and in patients with minimal-change nephrotic syndrome.
    Matsumoto K; Ohi H; Kanmatsuse K
    Nephron; 1999; 82(1):32-8. PubMed ID: 10224482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired T-lymphocyte colony formation in lipoid nephrosis.
    Matsumoto K; Okano K; Yoshizawa N; Harada M; Ohi H; Hatano M
    Clin Nephrol; 1985 Dec; 24(6):279-84. PubMed ID: 3878248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-17 stimulates the release of pro-inflammatory cytokines by blood monocytes in patients with IgA nephropathy.
    Matsumoto K; Kanmatsuse K
    Scand J Urol Nephrol; 2003; 37(2):164-71. PubMed ID: 12745727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular permeability increasing factor (VPF) in IgA nephropathy.
    Bakker WW; Beukhof JR; van Luijk WH; van der Hem GK
    Clin Nephrol; 1982 Oct; 18(4):165-7. PubMed ID: 7140031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal tubular epithelial antigen-containing immune complexes stimulate interleukin-1 production by monocytes from patients with glomerulonephritis.
    Matsumoto K
    Int Urol Nephrol; 1992; 24(3):319-26. PubMed ID: 1399388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concanavalin A-induced suppressor cell activity in lipoid nephrosis.
    Osakabe K; Matsumoto K
    Scand J Immunol; 1981 Aug; 14(2):161-5. PubMed ID: 6458879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.